Cat. No. 3295
Chemical Name: N-Phthalyl-L-tryptophan
Biological ActivityNon-nucleoside DNA methyltransferase inhibitor that blocks the enzyme active site. Inhibits DNA methylation in human cancer cell lines in vitro without detectable toxicity. Demethylates and reactivates epigenetically silenced tumor suppressor genes. Enhances the efficiency of induced pluripotent stem cell (iPS) generation.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Brueckner et al (2005) Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of DNA methyltransferase. Cancer Res. 65 6305. PMID: 16024632.
Schirrmacher et al (2006) Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferases. Bioconjug.Chem. 17 261. PMID: 16536454.
Stresemann et al (2006) Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res. 66 2794. PMID: 16510601.
Liang et al (2010) Butyrate promotes iPS cell generation. J.Biol.Chem. 285 25516. PMID: 20554530.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: RG 108, supplier, Non-nucleoside, DNA, methyltransferase, inhibitor, inhibitors, transferases, RG108, inhibits, DNA, methylation, dnmt, epigenetics
Find multiple products by catalog number
New Products in this Area
NMPRTase inhibitor; also induces autophagyIWP L6
Potent Porcn inhibitorNU 9056
Inhibitor of KAT5 (Tip60) histone acetyltransferaseCystamine dihydrochloride
Transglutaminase inhibitor; neuroprotective
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.